← Leaderboards
Bruce C Trapnell
Children'S Hospital Med Ctr (Cincinnati)
$24,819,705
Attributed
$30,618,009
Total exposure
27
Grants
21
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.2M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$39,714,317 · 28
FDA$300,000 · 1
By mechanism
U54$16,774,459 · 9
R01$14,075,347 · 5
R33$5,061,587 · 1
T32$2,660,216 · 1
R61$799,832 · 1
R21$409,673 · 1
Top collaborators
- Francis X Mccormack12 shared
- Jeffrey A Whitsett11 shared
- Jeffrey P Krischer5 shared
- Jason C Woods5 shared
- Bruce Colston Trapnell4 shared
Most similar at Children'S Hospital Med Ctr (Cincinnati)
Same institution · by research overlap
- Machiko Ikegami$6,492,897
- Timothy Edward Weaver$15,703,230
- Stephan W. Glasser$4,593,350
- Xinhua Lin$7,017,500
- Susan E Wert$3,077,905
Others in their field
Top investigators on “Lung”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$372,040,227
- Chanza Baytop · Westat, Inc.$271,217,917
- Richard K. Wilson · Washington University$201,818,043
- Walter John Curran · Thomas Jefferson University$112,093,071
Research focus
LungPathogenesisLung DiseasesPulmonary Alveolar ProteinosisAlveolar MacrophagesBaseDiagnosticGranulocyte-Macrophage Colony-Stimulating FactorProgramsSignal TransductionDiagnosisMolecularRespiratory FailureSurfactantMutationFutureAlveolarClinical ResearchOutcome MeasureMacrophageReportingUnited States National Institutes Of HealthHomeostasisChild
Grant awards (103)
Human gene transfer & macrophage cell transplantation therapy of hereditary PAP (hPAP)$1,112,296
R33 · FY2025 · HL · contact PI
Human gene transfer & macrophage cell transplantation therapy of hereditary PAP (hPAP)$1,817,287
R33 · FY2024 · HL · contact PI
Pulmonary Development and Disease Pathogenesis Training Program$230,990
T32 · FY2024 · HL
Human gene transfer & macrophage cell transplantation therapy of hereditary PAP (hPAP)$2,132,004
R33 · FY2023 · HL · contact PI
Pathogenesis-Based Diagnostics and Pharmacotherapeutics for PAP$397,500
R01 · FY2023 · HL · contact PI
Pulmonary Development and Disease Pathogenesis Training Program$379,406
T32 · FY2023 · HL
Pathogenesis-Based Diagnostics and Pharmacotherapeutics for PAP$397,500
R01 · FY2022 · HL · contact PI
Human gene transfer & macrophage cell transplantation therapy of hereditary PAP (hPAP)$389,225
R61 · FY2022 · HL · contact PI
Retrospective Autoimmune PAP Natural History and Patient-Reported Outcomes Study$300,000
R01 · FY2022 · FD · contact PI
Pulmonary Development and Disease Pathogenesis Training Program$280,349
T32 · FY2022 · HL
Pulmonary Macrophage Transplantation for Pulmonary Alveolar Proteinosis$459,701
R01 · FY2021 · HL · contact PI
Human gene transfer & macrophage cell transplantation therapy of hereditary PAP (hPAP)$410,607
R61 · FY2021 · HL · contact PI
Pathogenesis-Based Diagnostics and Pharmacotherapeutics for PAP$397,500
R01 · FY2021 · HL · contact PI
Pulmonary Development and Disease Pathogenesis Training Program$349,022
T32 · FY2021 · HL
Pulmonary Macrophage Transplantation for Pulmonary Alveolar Proteinosis$459,701
R01 · FY2020 · HL · contact PI
Pathogenesis-Based Diagnostics and Pharmacotherapeutics for PAP$397,500
R01 · FY2020 · HL · contact PI
Pulmonary Development and Disease Pathogenesis Training Program$343,890
T32 · FY2020 · HL
Pulmonary Macrophage Transplantation for Pulmonary Alveolar Proteinosis$459,701
R01 · FY2019 · HL · contact PI
Pathogenesis-Based Diagnostics and Pharmacotherapeutics for PAP$390,000
R01 · FY2019 · HL · contact PI
RLDC: Molecular Pathway-Driven Diagnostics & Therapeutics for Rare Lung Diseases$625,000
U54 · FY2018 · HL · contact PI
Pulmonary Macrophage Transplantation for Pulmonary Alveolar Proteinosis$505,189
R01 · FY2018 · HL · contact PI
Pathogenesis-Based Diagnostics and Pharmacotherapeutics for PAP$390,000
R01 · FY2018 · HL · contact PI
Admin Core$294,051
U54 · FY2018 · HL · contact PI
Hermansky-Pudlak Syndrome$149,123
U54 · FY2018 · HL · contact PI
Lymphangioleiomyomatosis$90,667
U54 · FY2018 · HL · contact PI
Pulmonary Alveolar Proteinosis Syndrome$84,714
U54 · FY2018 · HL · contact PI
Lung and Cardiovascular Development and Disease Pathogenesis Training Program$71,755
T32 · FY2018 · HL
The 2018 International Rare Lung Diseases Clinical Research Conference$40,000
R13 · FY2018 · HL · contact PI
Pilot and Demonstration Project Program$6,445
U54 · FY2018 · HL · contact PI
RLDC: Molecular Pathway-Driven Diagnostics & Therapeutics for Rare Lung Diseases$625,000
U54 · FY2017 · HL · contact PI
Macrophage Based Gene Therapy for Hereditary Pulmonary Alveolar Proteinosis$554,394
R01 · FY2017 · HL · contact PI
Pathogenesis-Based Diagnostics and Pharmacotherapeutics for PAP$390,000
R01 · FY2017 · HL · contact PI
Admin Core$301,149
U54 · FY2017 · HL · contact PI
Lung and Cardiovascular Development and Disease Pathogenesis Training Program$183,203
T32 · FY2017 · HL
Hermansky-Pudlak Syndrome$149,123
U54 · FY2017 · HL · contact PI
Lymphangioleiomyomatosis$86,554
U54 · FY2017 · HL · contact PI
Pulmonary Alveolar Proteinosis Syndrome$78,669
U54 · FY2017 · HL · contact PI
Pilot and Demonstration Project Program$9,505
U54 · FY2017 · HL · contact PI
Lung and Cardiovascular Development and Disease Pathogenesis Training Program$4,549
T32 · FY2017 · HL
Macrophage Based Gene Therapy for Hereditary Pulmonary Alveolar Proteinosis$664,101
R01 · FY2016 · HL · contact PI
RLDC: Molecular Pathway-Driven Diagnostics & Therapeutics for Rare Lung Diseases$625,000
U54 · FY2016 · HL · contact PI
Pathogenesis-Based Diagnostics and Pharmacotherapeutics for PAP$390,000
R01 · FY2016 · HL · contact PI
Lung and Cardiovascular Development and Disease Pathogenesis Training Program$303,926
T32 · FY2016 · HL
Admin Core$292,503
U54 · FY2016 · HL · contact PI
Hermansky-Pudlak Syndrome$149,123
U54 · FY2016 · HL · contact PI
Lymphangioleiomyomatosis$87,157
U54 · FY2016 · HL · contact PI
Pulmonary Alveolar Proteinosis Syndrome$86,712
U54 · FY2016 · HL · contact PI
The 2016 International Rare Lung Diseases Clinical Research Conference$15,000
R13 · FY2016 · HL · contact PI
Pilot and Demonstration Project Program$9,505
U54 · FY2016 · HL · contact PI
Macrophage Based Gene Therapy for Hereditary Pulmonary Alveolar Proteinosis$688,563
R01 · FY2015 · HL · contact PI
RLDC: Molecular Pathway-Driven Diagnostics & Therapeutics for Rare Lung Diseases$615,624
U54 · FY2015 · HL · contact PI
Role of GM-CSF in Myeloid Cell Function and Innate Immunity$369,728
R01 · FY2015 · HL · contact PI
Admin Core$287,423
U54 · FY2015 · HL · contact PI
RLDC: Molecular Pathway-Driven Diagnostics & Therapeutics for Rare Lung Diseases$227,760
U54 · FY2015 · HL · contact PI
Lung and Cardiovascular Development and Disease Pathogenesis Training Program$221,240
T32 · FY2015 · HL
Hermansky-Pudlak Syndrome$150,289
U54 · FY2015 · HL · contact PI
Lymphangioleiomyomatosis$85,302
U54 · FY2015 · HL · contact PI
Pulmonary Alveolar Proteinosis Syndrome$83,249
U54 · FY2015 · HL · contact PI
Pilot and Demonstration Project Program$9,361
U54 · FY2015 · HL · contact PI
RLDC: Molecular Pathway-Driven Diagnostics & Therapeutics for Rare Lung Diseases$937,500
U54 · FY2014 · HL · contact PI
Macrophage Based Gene Therapy for Hereditary Pulmonary Alveolar Proteinosis$668,282
R01 · FY2014 · HL · contact PI
Admin Core$488,175
U54 · FY2014 · HL · contact PI
Role of GM-CSF in Myeloid Cell Function and Innate Immunity$367,852
R01 · FY2014 · HL · contact PI
Lung and Cardiovascular Development and Disease Pathogenesis Training Program$291,886
T32 · FY2014 · HL
Hermansky-Pudlak Syndrome$192,195
U54 · FY2014 · HL · contact PI
Pulmonary Alveolar Proteinosis Syndrome$145,153
U54 · FY2014 · HL · contact PI
Lymphangioleiomyomatosis$102,472
U54 · FY2014 · HL · contact PI
Pilot and Demonstration Project Program$9,505
U54 · FY2014 · HL · contact PI
Role of GM-CSF in Myeloid Cell Function and Innate Immunity$357,342
R01 · FY2013 · HL · contact PI
Role of GM-CSF in Myeloid Cell Function and Innate Immunity$375,359
R01 · FY2012 · HL · contact PI
Macrophage-based Human Gene Therapy for Hereditary PAP$218,788
R21 · FY2012 · HL · contact PI
Role of GM-CSF in Myeloid Cell Function and Innate Immunity$382,188
R01 · FY2011 · HL · contact PI
Macrophage-based Human Gene Therapy for Hereditary PAP$190,885
R21 · FY2011 · HL · contact PI
Role of Anti-GM-CSF Antibodies in Myeloid Cell Function & Innate Immunity$375,000
R01 · FY2010 · HL · contact PI
Role of Anti-GM-CSF Antibodies in Myeloid Cell Function & Innate Immunity$375,000
R01 · FY2009 · HL · contact PI
Rare Lung Disease Clinical Research Network$655,548
U54 · FY2008 · RR · contact PI
Role of Anti-GM-CSF Antibodies in Myeloid Cell Function & Innate Immunity$375,000
R01 · FY2008 · HL · contact PI
ANTICYTOKINE AUTOANTIBODIES/GROWTH FACTORS IN RARE LUNG DISEASES$14,565
M01 · FY2008 · RR · contact PI
QUANTITATIVE CHEST COMPUTED TOMOGRAPHY IN ALPHA-1-ANTITRYPSIN DEFICIENCY$520
M01 · FY2008 · RR · contact PI
Role of Anti-GM-CSF Antibodies in Myeloid Cell Function & Innate Immunity$375,000
R01 · FY2007 · HL · contact PI
ANTICYTOKINE AUTOANTIBODIES/GROWTH FACTORS IN RARE LUNG DISEASES$25,627
M01 · FY2007 · RR · contact PI
RARE LUNG DISEASE CLINICAL RESEARCH NETWORK$1,167,021
U54 · FY2006 · RR · contact PI
Rare Lung Disease Clinical Research Network$1,044,178
U54 · FY2006 · RR · contact PI
Regulation of Alveolar Macrophage Phagocytosis$363,746
R01 · FY2006 · HL · contact PI
Rare Lung Disease Clinical Research Network$122,843
U54 · FY2006 · RR · contact PI
ANTICYTOKINE AUTOANTIBODIES/GROWTH FACTORS IN RARE LUNG DISEASES$40,169
M01 · FY2006 · RR · contact PI
AAT Deficiency & Liver Diseases Caused by Proteins$30,000
R13 · FY2006 · DK · contact PI
Fourth Annual International Pulmonary Alveolar Proteinosis Research Conference$15,000
R13 · FY2006 · HL · contact PI
RARE LUNG DISEASE CLINICAL RESEARCH NETWORK$1,094,604
U54 · FY2005 · RR
Rare Lung Disease Clinical Research Network$1,094,604
U54 · FY2005 · RR
Regulation of Alveolar Macrophage Phagocytosis$372,500
R01 · FY2005 · HL
Pulmonary Alveolar Proteinosis Research Conference$20,000
R13 · FY2005 · HL
ANTICYTOKINE AUTOANTIBODIES/GROWTH FACTORS IN RARE LUNG DISEASES$5,072
M01 · FY2005 · RR
RARE LUNG DISEASE CLINICAL RESEARCH NETWORK$1,688,402
U54 · FY2004 · RR
Rare Lung Disease Clinical Research Network$1,688,402
U54 · FY2004 · RR
Regulation of Alveolar Macrophage Phagocytosis$372,500
R01 · FY2004 · HL
GM-CSF &Alveolar Macrophage Antiviral Lung Defense$333,000
R01 · FY2004 · HL
Conference--Pulmonary Alveolar Proteinosis Research$27,250
R13 · FY2004 · HL
Rare Lung Disease Clinical Research Network$1,134,849
U54 · FY2003 · RR
Regulation of Alveolar Macrophage Phagocytosis$372,500
R01 · FY2003 · HL
GM-CSF &Alveolar Macrophage Antiviral Lung Defense$333,000
R01 · FY2003 · HL
GM-CSF &Alveolar Macrophage Antiviral Lung Defense$333,000
R01 · FY2002 · HL
GM-CSF &Alveolar Macrophage Antiviral Lung Defense$333,000
R01 · FY2001 · HL